Luis Checa

Luis Checa is a seasoned product manager with extensive experience in hematology, oncology, immunology, rare diseases, and women's healthcare across Central America and the Caribbean. Currently serving as a Hematology-Oncology Product Manager at Adium since October 2021, Luis leads the launch of significant products such as Zanubrutunib and Blinatumomab. Prior roles include managing cancer and localized neuropathic pain products at El Grupo Grünenthal, as well as overseeing gastrointestinal and cardiology portfolios at AstraZeneca. Luis holds an MBA from IMD and has furthered education in business strategy and management through several prestigious programs. Demonstrated strengths include strategic planning, market positioning, and stakeholder engagement aimed at delivering compelling value propositions in healthcare.